MedTrace Logo

The Effects of Coenzyme A Combined With Statin on Serum Lipids in Patients With Hyperlipidemia

NCT01928342 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 320

Last updated 2013-08-23

No results posted yet for this study

Summary

The purpose of this study is to evaluate the lipid lowering effects and clinical safety of a natural hypolipidemic compound, coenzyme A （CoA） capsule, combined use with statin, in Chinese patients with moderate dyslipidemia.

Conditions

  • Hyperlipoproteinemia

Interventions

DRUG

Coenzyme A

Coenzyme A 400mg per day

DRUG

Placebo

Capsule without coenzyme A.

Sponsors & Collaborators

  • Zhejiang University

    lead OTHER

Principal Investigators

  • Junzhu Chen · Zhejiang University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2013-09-30
Completion
2013-10-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01928342 on ClinicalTrials.gov